Adenocarcinoma arising from the ampulla of Vater is a rare disease and has limited data regarding outcome of chemotherapy. The ampulla of Vater is a heterogeneous junctional structure located at the union of the common bile duct, the pancreatic duct, and the small intestine. Thus, ampullary adenocarcinoma is classified as either intestinal type or pancreatobiliary type. We investigated the efficacy of the XELOX (capecitabine plus oxaliplatin) chemotherapy in patients with recurrent or metastatic ampullary adenocarcinoma, and analyzed the histopathologic features and outcomes. From November 2009 to December 2011, 21 patients were treated with XELOX regimen. XELOX was administered in outpatient clinic every 3 weeks according to the following ...
Background/Objective: The benefit of adjuvant therapy in ampullary cancer (AMPAC) patients following...
<p>Purpose: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range ...
Background/Aims: The efficacy and tolerability of oxaliplatin in combination with either folinic aci...
Ampullary adenocarcinoma is a rare tumor that arises from the ampulla of Vater; the confluence of th...
Carcinomas of the Ampulla of Vater are rare tumors, accounting for 0.2% of gastrointestinal cancers....
Background. The clinical relevance of the classification of ampullary adenocarcinoma (AC) into pancr...
Background: Whether patients who undergo resection of ampullary adenocarcinoma have a survival benef...
Introduction. Ampullary cancers represent a subset of periampullary cancers, comprising only 0.2% al...
Purpose: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range of outcom...
PURPOSE: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range of outco...
Objective: To evaluate the clinicopathologic features and prognosis of ampullary adenocarcinoma (AA)...
Ampullary carcinoma is a rare tumor and evidence on the treatment of recurrent metastatic disease is...
Periampullary cancers include pancreatic, ampullary, biliary and duodenal cancers. At presentation, ...
Periampullary cancers include pancreatic, ampullary, biliary and duodenal cancers. At presentation, ...
Ampullary cancer is a rare gastrointestinal malignancy that can be curable with surgical resection o...
Background/Objective: The benefit of adjuvant therapy in ampullary cancer (AMPAC) patients following...
<p>Purpose: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range ...
Background/Aims: The efficacy and tolerability of oxaliplatin in combination with either folinic aci...
Ampullary adenocarcinoma is a rare tumor that arises from the ampulla of Vater; the confluence of th...
Carcinomas of the Ampulla of Vater are rare tumors, accounting for 0.2% of gastrointestinal cancers....
Background. The clinical relevance of the classification of ampullary adenocarcinoma (AC) into pancr...
Background: Whether patients who undergo resection of ampullary adenocarcinoma have a survival benef...
Introduction. Ampullary cancers represent a subset of periampullary cancers, comprising only 0.2% al...
Purpose: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range of outcom...
PURPOSE: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range of outco...
Objective: To evaluate the clinicopathologic features and prognosis of ampullary adenocarcinoma (AA)...
Ampullary carcinoma is a rare tumor and evidence on the treatment of recurrent metastatic disease is...
Periampullary cancers include pancreatic, ampullary, biliary and duodenal cancers. At presentation, ...
Periampullary cancers include pancreatic, ampullary, biliary and duodenal cancers. At presentation, ...
Ampullary cancer is a rare gastrointestinal malignancy that can be curable with surgical resection o...
Background/Objective: The benefit of adjuvant therapy in ampullary cancer (AMPAC) patients following...
<p>Purpose: Individuals with adenocarcinoma of the ampulla of Vater demonstrate a broad range ...
Background/Aims: The efficacy and tolerability of oxaliplatin in combination with either folinic aci...